Cinemark (NYSE:CNK)‘s stock had its “outperform” rating reaffirmed by investment analysts at Wedbush in a research report issued to clients and investors on Tuesday. They currently have a $38.00 target price on the stock, down from their previous target price of $40.00. Wedbush’s price objective would indicate a potential downside of 2.64% from the company’s previous close.
A number of other equities analysts also recently commented on CNK. Zacks Investment Research raised shares of Cinemark from a “sell” rating to a “hold” rating in a report on Wednesday, November 8th. B. Riley reaffirmed a “buy” rating and issued a $47.00 price objective on shares of Cinemark in a report on Tuesday, December 5th. Royal Bank of Canada raised shares of Cinemark from a “sector perform” rating to an “outperform” rating and lifted their price objective for the stock from $33.91 to $40.00 in a report on Wednesday, January 10th. MKM Partners reduced their price target on shares of Cinemark to $44.00 and set a “buy” rating for the company in a report on Wednesday, January 24th. Finally, Morgan Stanley boosted their price target on shares of Cinemark from $38.00 to $40.00 and gave the company an “equal weight” rating in a report on Wednesday, January 31st. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and eight have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $41.61.
Cinemark (NYSE:CNK) opened at $39.03 on Tuesday. The company has a market cap of $4,545.70, a price-to-earnings ratio of 18.50, a price-to-earnings-growth ratio of 1.08 and a beta of 1.15. The company has a quick ratio of 1.46, a current ratio of 1.50 and a debt-to-equity ratio of 1.50. Cinemark has a 1-year low of $32.03 and a 1-year high of $44.84.
Hedge funds have recently bought and sold shares of the stock. Cable Hill Partners LLC lifted its holdings in Cinemark by 3,300.0% in the third quarter. Cable Hill Partners LLC now owns 2,958 shares of the company’s stock worth $107,000 after purchasing an additional 2,871 shares during the period. Cerebellum GP LLC acquired a new stake in Cinemark in the fourth quarter worth about $118,000. Ffcm LLC acquired a new stake in Cinemark in the third quarter worth about $125,000. Zions Bancorporation acquired a new stake in Cinemark in the third quarter worth about $125,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Cinemark by 54.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,862 shares of the company’s stock worth $204,000 after purchasing an additional 2,070 shares during the period. 93.93% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This report was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.chaffeybreeze.com/2018/02/20/cinemarks-cnk-outperform-rating-reiterated-at-wedbush.html.
Cinemark Holdings, Inc is engaged in the motion picture exhibition business with theatres in the United States (U.S.), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Paraguay, Curacao and Bolivia. The Company manages its business in two segments: U.S.
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.